| Overview |
| bs-2370R-PE |
| FABP5 Polyclonal Antibody, PE Conjugated |
| FCM |
| Mouse, Others |
| Human, Rat, Pig, Horse |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Fatty Acid Binding Protein 5 |
| 21-120/135 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 2171 |
| Cytoplasm |
| epidermal; Fatty Acid Binding Protein 5; CFABP; Cutaneous fatty acid binding protein; DA11; Dferentiation associated lipid binding protein LP2; E-FABP; EFABP; Epidermal-type fatty acid-binding protein; FABP5; FABP5_HUMAN; Fatty acid binding protein epidermal; Fatty acid-binding protein 5; Fatty acid-binding protein; Keratinocyte lipid binding protein; PA-FABP; PAFABP; Psoriasis associated fatty acid binding protein homolog; Psoriasis-associated fatty acid-binding protein homolog. |
| This gene encodes the fatty acid binding protein found in epidermal cells, and was first identified as being upregulated in psoriasis tissue. Fatty acid binding proteins are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. FABPs may play roles in fatty acid uptake, transport, and metabolism. Polymorphisms in this gene are associated with type 2 diabetes. The human genome contains many pseudogenes similar to this locus.[provided by RefSeq, Feb 2011]. |
| Application Dilution |
| FCM |
1:20-100 |
Powered by Bioz